Rationing and competition in the Dutch health-care system

Health Economics

Volumn 14, Issue SUPPL. 1, 2005, Pages

  Schut, Frederik T ^a,b   Van de Ven, Wynand P M M ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b NONE   (Netherlands)

Author keywords

Health care; Regulated competition; The Netherlands

Indexed keywords

ARTICLE; COST CONTROL; FEASIBILITY STUDY; FINANCIAL MANAGEMENT; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH INSURANCE; HEALTH SERVICE; NETHERLANDS; OUTCOMES RESEARCH; PRIORITY JOURNAL; REIMBURSEMENT; RESOURCE ALLOCATION; RISK ASSESSMENT; SOCIAL INSURANCE;

COST CONTROL; FINANCIAL MANAGEMENT; HEALTH CARE RATIONING; HEALTH CARE REFORM; HEALTH SERVICES ACCESSIBILITY; HUMANS; MOTIVATION; NATIONAL HEALTH PROGRAMS; NETHERLANDS; QUALITY ASSURANCE, HEALTH CARE;

EID: 26044480847     PISSN: 10579230     EISSN: None     Source Type: Journal    
DOI: 10.1002/hec.1036     Document Type: Article

References (45)

1. Hurst J. The reform of health care systems in seven OECD countries. Paper presented at the Second World Congress on Health Economics, Zurich, 1990.
2. Scotton RB. National health insurance in Australia: new concepts and new applications. Working Paper No. 11, National Centre for Health Program Evaluation, Melbourne, 1991.
3. Cutler D. Equality, efficiency, and market fundamentals: the dynamics of international medical-care reform. J Econ Literature 2002; 60: 881-906.
4. Government Committee on Choices in Health Care. Choices in Health Care. Ministry of Welfare, Health and Cultural Affairs: Rijswijk, 1992.
5. Lieverdink H, Maarse H. Negotiating fees for medical specialists in the Netherlands. Health Policy 1995; 31: 81-101.
6. Scholten GRM, Roex AJM, Sindram JW. Cost-control and medical specialist payment: the Dutch alternative. Int J Health Plann Manage 1998; 13: 69-83.
7. SFK. Data en feiten 2002. Stichting Farmaceutische Kengetallen: Den Haag, 2002.
8. Commissie Dekker. Bereidheid tot verandering. Distributiecentrum Overheidspublicaties: Den Haag, 1987.
9. Enthoven AC. Consumer-choice health plan; a national-health-insurance proposal based on regulated competition in the private sector. N Engl J Med 1978; 298: 709-720.
10. Enthoven AC. The Theory and Practice of Managed Competition. North-Holland, Elsevier: Amsterdam, 1988.
11. Helderman JK, Schut FT, Van der Grinten TED, Van de Ven WPMM. Market-oriented health care reforms and policy learning in the Netherlands. J Health Polit Policy Law 2005; 30(1/2): 189-209.
12. Lamers LM, van Vliet RCJA, Van de Ven WPMM. Risk adjusted premium subsidies and risk sharing: key elements of the competitive sickness fund market in the Netherlands. Health Policy 2003; 65: 49-62.
13. Van de Ven WPMM, Ellis RP. Risk adjustment in competitive health plan markets. In Handbook of Health Economics, Culyer AJ, Newhouse JP (eds). Elsevier Science: Amsterdam, 2000; 755-845.
14. Van de Ven WPMM, van Vliet RCJA, Lamers LM. Health-adjusted premium subsidies in the Netherlands. Health Affairs 2004; 23(3): 45-54.
15. Or Z. Improving the performance of health care systems: from measures to action: a review of experiences in four OECD countries. Labour market and social policy - Occasional Papers No. 57. OECD: Paris, 2002.
16. Consumentenbond. Welk ziekenhuis kies ik? Informatie over circa 100 Nederlandse ziekenhuizen. Consumentenbond: Den Haag, 2002.
17. Ministry of Health (VWS). Vraag aan bod. Tweede Kamer, 27855 (2), SDU, Den Haag, 2001.
18. Linssen RJL. Evaluatie macro-economische effecten Algemene Eigen Bijdrageregeling voor ziekenfondsverzekerden. SCP, Report nr. 50, Rijswijk, 1998.
19. Maarse JAM. Hospital budgeting in Holland: aspects, trends and effects. Health Policy 1989; 11: 257-276.
20. Maarse JAM, van der Horst A, Molin EJE. Hospital budgeting in the Netherlands. Effects upon hospital services. Eur J Public Health 1993; 3: 181-187.
21. Casparie AF, Hoogendoorn D. Effects of budgeting on health care services in Dutch hospitals. Am J Public Health 1991; 81: 1442-1447.
22. Schut FT. Competition in the Dutch health care sector. PhD Dissertation, Erasmus University, Rotterdam, 1995.
23. Mot ES. Paying the medical specialist: the eternal puzzle. Experiments in the Netherlands. PhD Dissertation, University of Amsterdam, Amsterdam, 2002.
24. Friele RD, Dane A, Andela M. Wachten duurt lang. Het oordeel van patiënten over aanvaardbare wachttijden. Med Contact 2001; 56(14): 542-544.
25. Bon R, van der Maten M. Wachttijden in ziekenhuizen. Verslag van een verkenning naar de praktijk van ziekenhuizen en verzekeraars. Ministerie van VWS: Den Haag, 2002.
26. Jeurissen PPT. Nieuwe aanbieders onder de loep: een onderzoek naar private initiatieven in de gezondheidszorg. RVZ, Zoetermeer, 2002.
27. Brouwer WBF, Schut FT. Priority care for employees: a blessing in disguise? Health Econ 1999; 8: 65-73.
28. SEO. Wachtlijsten: een duur medicijn. Stichting voor Economisch Onderzoek: Amsterdam, 2001.
29. Ministry of Health (VWS). Rijksbegroting Volksgezondheid, Welzijn en Sport. Tweede Kamer, 29200 hoofdstuk XVI, nr.2, 2003; 21.
30. CBS. Zorgrekeningen; kerncijfers en uitgaven conform diverse classificaties. Statistics Netherlands, http://statline.ebs.nl/StatWeb/,Heerlen, 2004.
31. Kerssens JJ. Het geneesmiddelenvergoedingssysteem: gevolgen voor de patiënt. Medisch Contact 1992; 47: 1028-1030.
32. CVZ. Wet Geneesmiddelenprijzen: effectief instrument voor kostenbeheersing. Raadzaam 1997; 7: 20.
33. Ziekenfondsraad. Opname nieuwe geneesmiddelen in het pakket. Publicatienummer 746, Ziekenfondsraad, Amstelveen, 1997.
34. Starmans HBG, Verkooijen JMHFM, Vander-Broeck MJAP. Het effect van eigen betalingen in de Nederlandse gezondheidszorg: casus poliklinische specialistenhulp. Tijdschr Soc Gezondheidszorg 1993; 71: 223-230.
35. Post D. Eigen bijdrage en prescriptie. Medisch Contact 1985; 40: 687-689.
36. Delnoij DMJ, Hutten JBF, Ros CC, Groenewegen PP, Friele RD, van Lisdonk E, de Bakker DH. Effect van eigen bijdragen in het ziekenfonds in Nederland. Tijdschr Soc Gezondheidszorg 1999; 77: 406-412.
37. Janssen E, van Doorslaer E. Verdeling van de zorglasten voor en na de stelselwijziging. Instituut Beleid en Management Gezondheidszorg, Erasmus Universiteit Rotterdam: Rotterdam, 2002.
38. Le Grand J, Vizard P. The National Health Service: crisis, change, or continuity? In The State of Welfare - The Economics of Social Spending (2nd edn), Glennerster H, Hills J (eds). Oxford University Press: Oxford, 1998; 75-121.
39. Mackenbach JP. The contribution of medical care to mortality decline: McKeown revisited. J Clin Epidemiol 1996; 49: 1207-1213.
40. Van Oers JAM (ed.). Gezondheid op Koers? Volksgezondheid Toekomst Verkenning, RIVM: Bilthoven, 2002.
41. Beaujean DJMA, Hutten JBF, Groenewegen PP. Sluipend kwaliteitsverlies: medisch specialisten over probleemsituaties in de zorg. Medisch Contact 2002; 57: 924-927.
42. Schut FT, Hassink WHJ. Managed competition and consumer price sensitivity in social health insurance. J Health Econ 2002; 21: 1009-1029.
43. Schut FT, Gresz S, Wasem J. Consumer price sensitivity and social health insurer choice in Germany and the Netherlands. Int J Health Care Finance Econ 2003; 3: 117-138.
44. Van de Ven WPMM, Schut, FT. Should catastrophic risks be included in a regulated competitive health insurance market? Soc Sci Med 1994; 39: 1459-1472.
45. Paolucci F, Den Exter A, Van de Ven WPMM. Solidarity in competitive health insurance markets: analyzing the relevant EC legal framework. Paper presented at the 5th European Conference on Health Economics in London, Erasmus University Rotterdam, Rotterdam, 2004.